A Clinical Trial to Investigate the Efficacy and Safety of Evogliptin

A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 160 participants.

Also called NCT02946541

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; quadruple masking; primary purpose treatment
Phase
Phase 3
Enrolled
  • 160 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT02946541
Start date
(registry gives no type) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
South Korea (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT02946541. Randomized; quadruple masking; primary purpose treatment. Start 2013-07 (registry gives no type); primary completion 2014-10 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
A Clinical Trial to Investigate the Efficacy and Safety of Evogliptin
Condition
Type 2 Diabetes Mellitus
Intervention (Drug)
evogliptin 5mg
Intervention (Drug)
Placebo
Lead sponsor
Dong-A ST Co., Ltd. (class: industry)

Record details

Record id
cardio:ct-nct02946541
Content hash
3bd2d06fedf4c451d6e7139476d051c9ca52353dc73cc55e6962ee0da379e4bc